Market Analysis - Neuro-Ophthalmology 2018
Global market research of ophthalmology
The global ophthalmology market
witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases
, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Moreover, incidences of glaucoma and cataract are increasing every year.
is responsible for 48% of the population becoming totally blind. In addition, more than 60 million people suffer from glaucoma and this number is expected to reach 80 million by 2020. An increasing aging population is also resulting in more people suffering from refractive errors. It is estimated that in the U.S. and Europe, refractive errors affect more than 30% of the population aged 40 or older. However, the economic slowdown and drying pipeline of ophthalmology drugs is restricting the market.
Scope of the Report
The research report categorizes the global ophthalmology drugs
and devices market into diagnostic devices, surgical devices, vision care and drugs. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analysed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario. However, the drugs market is analysed in the U.S., Europe, Japan, Asia, and Rest of the world.
According to WHO:
- 285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 have low vision.
- About 90% of the world’s visually impaired live in low-income settings.
- 82% of people living with blindness are aged 50 and above.
- Globally, uncorrected refractive errors are the main cause of moderate and severe visual impairment; cataracts remain the leading cause of blindness in middle- and low-income countries.
- The number of people visually impaired from infectious diseases has reduced in the last 20 years according to global estimates work.
- 80% of all visual impairment can be prevented or cured.
- Cataract removal is the most commonly performed ophthalmic surgical operation
Why Osaka, Japan?
is the most populous city in the Japan which is developed very rapidly and become the attraction for all kinds of investments. It is the tourist hub and known for the luxury and comfort and thus it makes the perfect destination for Neuro-Ophthalmology 2018.
A booming population, growing prevalence of lifestyle diseases and mandatory health insurance policies are fuelling the growth of private sector firms in the Japan’s healthcare industry.
Japan’s private hospitals were valued at $1.75 billion in 2013 but are expected to reach $3.23 billion by 2020, according to a new report by research firm Colliers International.
The report revealed that population growth, prevalence of lifestyle diseases, introduction of compulsory health insurance along with the emirate’s push to become a medical tourism hub are expected to drive the growth of the private sector in Japan’s healthcare industry
Ophthalmic Drugs & Devices – Market Analysis
The Global Ophthalmic Device Market
is poised to grow at a CAGR of around 4.8% over the next decade to reach approximately $71.9 billion by 2025. According to a new market report published by Transparency Market Research "Ophthalmology Diagnostics and Surgical Devices Market (Optical Coherence Tomography, Echography, Corneal Topographers, Specular Microscopes, Cataract, Refractive, Glaucoma and Vitreous retinal Surgery Devices)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Ophthalmology Devices market was valued at USD26,012.6million in 2012 and estimated to reach a market worth USD40,381.6 million in 2019 at a CAGR of 6.6 % from 2013 to 2019. Asia Pacific ophthalmic drugs & devices market was valued at $11815.02 million in 2016 and is expected to reach $20920.43 million by 2025 growing at a CAGR of 6.64% during the forecast period of 2017-2025.
Eye care in Japan
is expected to post a value CAGR of 1% at constant 2016 prices over the forecast period, reaching sales of JPY81 billion in 2021. Standard eye care, which accounted for an 87% share of overall eye care value sales, also registered a healthy increase of 3%, driven by more expensive hybrid products. There is a movement in Japan to provide optometric education and qualifying examinations comparable to international standards.
World Congress on Clinical, Pediatric and Neuro Ophthalmology
is awaiting for its footsteps on October 3-4, 2018
at Osaka, Japan
which effectuates the great visualisation of Ophthalmologists, Optometrist, Ophthalmology Researchers, Scholars, Faculty people, Ophthalmic masters and powers, young examiners and distinctive vision business visionaries from around the globe to make the social affair a perfect stage to dole out and get encounter, propel joint endeavours across over industry and educational world, and assess the 21st century game plans and advancements in Clinical and Neuro Ophthalmology.
The meeting gathers peers from across the country and across the globe under single roof to held with the discussions on Neuro Ophthalmology, Perception and Visual Cognition, Pediatric Ophthalmology, Infant Vision, Clinical Ophthalmology, Retinal Care, Scrutiny of Visual Sensory System, Eye Health, Ocular and Neurologic Evaluation, Cosmetic /Aesthetic ophthalmology, Optometry and Vision science, Vision Science and Technologies of Ophthalmology, Neuroscience of Visual Impairment, Recent Researches in Vision Science and Ophthalmology.
The Congress follows the theme of “Blooming of Bionic Eye into Vision”
and promises to bring together internationally renowned speakers and scientists to create exciting and memorable events, filled with lively interactive sessions and world-class exhibitions. Join us!